A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers
Clinical trial NCT05900531 · COMPLETED
Trial details
- NCT number
- NCT05900531
- Sponsor
- Kallyope Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-21
- Primary completion
- 2023-05-03
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.